What is the potential impact of artificial intelligence on healthcare access and medical practice according to healthcare innovation leaders?
Answered at 22:05 in Healthcare Fixed: No Insurance Needed, Same Doctors, 60% Less - David Goldhill · Proven Podcast
What is the potential impact of artificial intelligence on healthcare access and medical practice according to healthcare innovation leaders?
AI could meaningfully improve diagnostic accuracy, how doctors practice medicine, patient record management, and the ability to treat various conditions with more personalized drugs and treatments at lower costs. Yet the biggest impact of AI in healthcare so far has been in revenue management and negotiation between providers and insurers rather than direct clinical improvements.
The promise of artificial intelligence in healthcare sounds straightforward: better diagnostics, faster treatment decisions, smarter data management. But according to David Goldhill, founder of Sesame, the American healthcare system has a habit of deploying innovation in ways that don't directly benefit patients. AI is no exception to this pattern.
The disconnect is structural. An AI-driven vision could result in declining costs, improved data quality, and better patient outcomes — but only if the incentives in the system aligned with patient benefit rather than profit extraction. As Goldhill explains on the Proven Podcast, the U.S. healthcare system currently operates under a different logic: nobody in the system can afford to lower their prices and remain profitable, which creates a perverse incentive structure that no amount of AI sophistication can overcome.
"Nobody in the healthcare system can make more money, can be more profitable by lowering their prices."
David Goldhill — Founder and CEO of Sesame, a healthcare marketplace platform. Goldhill spent decades as an entertainment executive, running television operations at Universal Studios and the Game Show Network, building networks and television content, before applying his expertise to transforming healthcare through direct price transparency and consumer choice.
This observation cuts to the heart of why AI deployment in healthcare has prioritized administrative and financial optimization over clinical innovation. Revenue management and payer-provider negotiation directly impact the bottom line for hospitals, insurers, and health systems — and that's where AI investment has concentrated. Improving diagnostic accuracy or patient outcomes does not translate into higher profit margins if the entire payment system is designed to extract value from opacity rather than efficiency.
Full answer and detailsRead the whole answer, key facts and every other question from this episode
In short
AI could meaningfully improve diagnostic accuracy, how doctors practice medicine, patient record management, and the ability to treat various conditions with more personalized drugs and treatments at lower costs.
David Goldhill · Healthcare Fixed: No Insurance Needed, Same Doctors, 60% Less - David Goldhill · Proven Podcast · answer at 22:05
Key takeaways
- Yet the biggest impact of AI in healthcare so far has been in revenue management and negotiation between providers and insurers rather than direct clinical improvements.
- The promise of artificial intelligence in healthcare sounds straightforward: better diagnostics, faster treatment decisions, smarter data management.
- David Goldhill — Founder and CEO of Sesame, a healthcare marketplace platform.
- This observation cuts to the heart of why AI deployment in healthcare has prioritized administrative and financial optimization over clinical innovation.
Quote to remember
“Nobody in the healthcare system can make more money, can be more profitable by lowering their prices.”
— David Goldhill
The full answer · about 2 min
AI could meaningfully improve diagnostic accuracy, how doctors practice medicine, patient record management, and the ability to treat various conditions with more personalized drugs and treatments at lower costs. Yet the biggest impact of AI in healthcare so far has been in revenue management and negotiation between providers and insurers rather than direct clinical improvements.
The promise of artificial intelligence in healthcare sounds straightforward: better diagnostics, faster treatment decisions, smarter data management. But according to David Goldhill, founder of Sesame, the American healthcare system has a habit of deploying innovation in ways that don't directly benefit patients. AI is no exception to this pattern.
The disconnect is structural. An AI-driven vision could result in declining costs, improved data quality, and better patient outcomes — but only if the incentives in the system aligned with patient benefit rather than profit extraction. As Goldhill explains on the Proven Podcast, the U.S. healthcare system currently operates under a different logic: nobody in the system can afford to lower their prices and remain profitable, which creates a perverse incentive structure that no amount of AI sophistication can overcome.
"Nobody in the healthcare system can make more money, can be more profitable by lowering their prices."
David Goldhill — Founder and CEO of Sesame, a healthcare marketplace platform. Goldhill spent decades as an entertainment executive, running television operations at Universal Studios and the Game Show Network, building networks and television content, before applying his expertise to transforming healthcare through direct price transparency and consumer choice.
This observation cuts to the heart of why AI deployment in healthcare has prioritized administrative and financial optimization over clinical innovation. Revenue management and payer-provider negotiation directly impact the bottom line for hospitals, insurers, and health systems — and that's where AI investment has concentrated. Improving diagnostic accuracy or patient outcomes does not translate into higher profit margins if the entire payment system is designed to extract value from opacity rather than efficiency.
More answers from this episode
- 0:27Why does the United States healthcare system cost significantly more than other developed nations despite being 3% of the world population?
- 8:55What is the actual cost of innovation in pharmaceutical development and how does competition affect pricing once drugs are established?
- 10:03How does third-party payment insurance structure distort competition and pricing in healthcare markets?
- 15:03What is the lifetime cost burden for an average American employee and their family participating in the healthcare system?
- 15:37How much of healthcare spending goes directly to administrative costs of the payment system rather than actual medical care?
- 18:42How does Sesame create price transparency and competition in healthcare services compared to insurer-negotiated rates?